tiprankstipranks
Trending News
More News >
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market
Advertisement

Atea Pharmaceuticals (AVIR) Technical Analysis

Compare
224 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Atea Pharmaceuticals’s (AVIR) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Atea Pharmaceuticals is a Buy.
Atea Pharmaceuticals’s (AVIR) 20-Day exponential moving average is 3.53, while Atea Pharmaceuticals’s (AVIR) share price is $3.49, making it a Sell.
Atea Pharmaceuticals’s (AVIR) 50-Day exponential moving average is 3.44, while Atea Pharmaceuticals’s (AVIR) share price is $3.49, making it a Buy.

Atea Pharmaceuticals (AVIR) Pivot Points

Aug 16, 2025, 03:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.37
3.42
3.46
3.51
3.56
3.61
3.65
Fibonacci
3.42
3.45
3.48
3.51
3.55
3.57
3.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Atea Pharmaceuticals (AVIR) Moving Averages

Aug 16, 2025, 03:35 AM
Period
Simple
Exponential
MA5
3.47Buy
3.49Buy
MA10
3.50Sell
3.52Sell
MA20
3.55Sell
3.53Sell
MA50
3.48Buy
3.44Buy
MA100
3.18Buy
3.32Buy
MA200
3.18Buy
3.33Buy
Atea Pharmaceuticals’s (AVIR) 10-Day exponential moving average is 3.52, while Atea Pharmaceuticals’s (AVIR) share price is $3.49, making it a Sell.
Atea Pharmaceuticals’s (AVIR) 100-Day exponential moving average is 3.32, while Atea Pharmaceuticals’s (AVIR) share price is $3.49, making it a Buy.
Atea Pharmaceuticals’s (AVIR) stock price is $3.49 and Atea Pharmaceuticals’s (AVIR) 50-day simple moving average is 3.48, creating a Buy signal.
Atea Pharmaceuticals’s (AVIR) stock price is $3.49 and Atea Pharmaceuticals’s (AVIR) 100-day simple moving average is 3.18, creating a Buy signal.
Atea Pharmaceuticals’s (AVIR) stock price is $3.49 and Atea Pharmaceuticals’s (AVIR) 200-day simple moving average is 3.18, creating a Buy signal.

Atea Pharmaceuticals (AVIR) Technical Indicators

Aug 16, 2025, 03:35 AM
Name
Value
Implied Action
RSI (14)
48.64
Neutral
STOCH (9,6)
37.92
Neutral
STOCHRSI (14)
25.60
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
18.41
Buy
Williams %R
-75.36
Buy
CCI (14)
-27.31
Neutral
ATR (14)
0.17
-
Ultimate Oscillator
32.04
Neutral
ROC
-6.42
Sell
Atea Pharmaceuticals’s (AVIR) Relative Strength Index (RSI) is 48.64, creating a Neutral signal.
Atea Pharmaceuticals’s (AVIR) Trend Strength Indicator (ADX) is 18.41, creating a Buy signal.
Atea Pharmaceuticals’s (AVIR) Commodity Channel Index (CCI) is -27.31, creating a Neutral signal.
Atea Pharmaceuticals’s (AVIR) Price Rate of Change (ROC) is -6.42, creating a Sell signal.

FAQ

Is AVIR a Buy, Hold, or Sell?
Based on AVIR’s technical indicators, AVIR is a Buy.
    What is AVIR’s RSI (14)?
    AVIR’s RSI (14) is 48.64, which suggests AVIR is a Neutral.
      What is AVIR’s MACD?
      AVIR’s MACD is >-0.01, which suggests AVIR is a Buy.
        What is AVIR’s 5-day moving average?
        AVIR’s 5-day moving average is 3.47, which suggests AVIR is a Buy.
          What is AVIR’s 20-day moving average?
          AVIR 20-day moving average is 3.55, which suggests AVIR is a Sell.
            What is AVIR’s 50-day moving average?
            AVIR’s 50-day moving average is 3.48, which suggests AVIR is a Buy.
              What is AVIR’s 200-day moving average?
              AVIR’s 200-day moving average is 3.18, which suggests AVIR is a Buy.
                What is AVIR’s Williams % R (14)?
                AVIR’s Williams % R (14) is -75.36, which suggests AVIR is a Buy.
                  What is AVIR’s CCI (14)?
                  AVIR’s CCI (14) is -27.31, which suggests AVIR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis